Patents by Inventor Faye Wu

Faye Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR INCREASING T-CELL FUNCTION
    Publication number: 20240158459
    Abstract: Provided herein are methods of increasing T-cell function and T-cells produced by these methods. Also provided herein are methods of treating a subject using T-cells produced by these methods.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 16, 2024
    Applicant: Kyverna Therapeutics, Inc.
    Inventors: John Lee, Erin O’Brien, Jordan Tsai, Lih-Yun Hsu, Faye Wu
  • Methods for increasing T-cell function
    Patent number: 11879003
    Abstract: Provided herein are methods of increasing T-cell function and T-cells produced by these methods. Also provided herein are methods of treating a subject using T-cells produced by these methods.
    Type: Grant
    Filed: October 21, 2022
    Date of Patent: January 23, 2024
    Assignee: Kyverna Therapeutics, Inc.
    Inventors: John Lee, Erin O'Brien, Jordan Tsai, Lih-Yun Hsu, Faye Wu
  • METHODS OF PRODUCING T REGULATORY CELLS, METHODS OF TRANSDUCING T CELLS, AND USES OF THE SAME
    Publication number: 20230330141
    Abstract: This document relates to methods and materials for treating a mammal having an autoimmune disease. For example, materials and methods for producing a T cell comprising a FOXP3 polypeptide. Methods and materials for treating a mammal having an autoimmune disease comprising administering to a mammal having an autoimmune disease an effective amount of a T cell are also provided herein.
    Type: Application
    Filed: November 11, 2022
    Publication date: October 19, 2023
    Applicant: Kyverna Therapeutics, Inc.
    Inventors: Mamle Quarmyne, Faye Wu, Jordan Tsai, John Lee, Jeffrey Greve, Joseph Cheng, Meghana Vijayraghavan
  • METHODS FOR INCREASING T-CELL FUNCTION
    Publication number: 20230174615
    Abstract: Provided herein are methods of increasing T-cell function and T-cells produced by these methods. Also provided herein are methods of treating a subject using T-cells produced by these methods.
    Type: Application
    Filed: October 21, 2022
    Publication date: June 8, 2023
    Applicant: Kyverna Therapeutics, Inc.
    Inventors: John Lee, Erin O'Brien, Jordan Tsai, Lih-Yun Hsu, Faye Wu
  • METHODS AND COMPOSITIONS FOR TREATING DISEASE USING TARGETED FOXP3+CD4+ T CELLS AND CELLULAR SUICIDE AGENTS
    Publication number: 20230056336
    Abstract: This document relates to methods and materials for treating a mammal having an autoimmune disease. For example, materials and methods for producing a T cell comprising a FOXP3 polypeptide and a cellular suicide agent are provided herein. Methods and materials for treating a mammal having an autoimmune disease comprising administering to a mammal having an autoimmune disease an effective amount of a T cell are also provided herein.
    Type: Application
    Filed: April 15, 2022
    Publication date: February 23, 2023
    Inventors: Lih-Yun Hsu, Faye Wu, Jeffrey Greve, Erin O'Brien, Jeanne Flandez, John Lee
  • METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS
    Publication number: 20220110975
    Abstract: This document relates to methods and materials for treating a mammal having an autoimmune disease. For example, materials and methods for producing a T cell comprising a FOXP3 polypeptide and a microRNA are provided herein. Also provided are methods of treating an autoimmune disease that include administering these T cells.
    Type: Application
    Filed: October 12, 2021
    Publication date: April 14, 2022
    Inventors: Sarah Levinson, John Lee, Jordan Tsai, Jeanne Flandez, Ashley Mahne, Faye Wu, Sasha Farina, Harsh Srivastava, Joseph Park, Jeffrey Greve, Fred Cohen
  • Method and/or system for magnetic localization
    Patent number: 11250318
    Abstract: A method of real time magnetic localization comprising: providing an artificial neural network field model that is calibrated and optimized for a predetermined magnet; receiving signals from one or more magnetic sensors; and solving the location of the magnet using the model based on the signals.
    Type: Grant
    Filed: May 7, 2014
    Date of Patent: February 15, 2022
    Assignees: Singapore University of Technology and Design, Massachusetts Institute of Technology (MIT)
    Inventors: Shaohui Foong, Faye Wu
  • METHODS OF PRODUCING T REGULATORY CELLS, METHODS OF TRANSDUCING T CELLS, AND USES OF THE SAME
    Publication number: 20220031751
    Abstract: This document relates to methods and materials for treating a mammal having an autoimmune disease. For example, materials and methods for producing a T cell comprising a FOXP3 polypeptide. Methods and materials for treating a mammal having an autoimmune disease comprising administering to a mammal having an autoimmune disease an effective amount of a T cell are also provided herein.
    Type: Application
    Filed: August 2, 2021
    Publication date: February 3, 2022
    Inventors: Mamle Quarmyne, Faye Wu, Jordan Tsai, John Lee, Jeffrey Greve, Joseph Cheng, Meghana Vijayraghavan
  • METHOD AND/OR SYSTEM FOR MAGNETIC LOCALIZATION
    Publication number: 20160086080
    Abstract: A method of real time magnetic localization comprising: providing an artificial neural network field model that is calibrated and optimized for a predetermined magnet; receiving signals from one or more magnetic sensors; and solving the location of the magnet using the model based on the signals.
    Type: Application
    Filed: May 7, 2014
    Publication date: March 24, 2016
    Applicants: Singapore University of Technology and Design, Massachusetts Institute of Technology
    Inventors: Shaohui Foong, Faye Wu
  • Factor VIII Muteins with Reduced Immonugenicity
    Publication number: 20110112022
    Abstract: The invention relates to modified Factor VIII molecules with reduced N-linked glycosylation and reduced immunogenicity. The invention also relates to methods of using modified Factor VIII molecules, for example, to treat patients afflicted with hemophilia.
    Type: Application
    Filed: June 25, 2009
    Publication date: May 12, 2011
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Fred Jullien Aswad, Richard Harkins, Hsiao-Lai Liu, John E. Murphy, Faye Wu, Ying Zhu